Funding profile · Dental AI

Adravision

A Singapore founded dental AI company with no SEC filing found under its own name, a Y Combinator check, and a 2024 accelerator investment tied to a required move to Atlanta. Here is what the public record shows, and what is only the company’s own account.

$230KTotal raised, third-party estimate (CB Insights, Oct 2024)
$250KRaised by Aug 2021, company-reported to TechCrunch
$125KY Combinator seed check dated Sep 2, 2021, per Tracxn
$100KBronze Valley SAFE for 5% equity, Feb 2024

Data as of September 24, 2026. Company-reported figures are labeled.

Rounds at a glance

When Round Amount Investors Source
2021 Y Combinator, Summer 2021 (S21) $125,000 per Tracxn; $250,000 total raised claimed by the company as of Aug 2021 Y Combinator Differs across sources
Feb 2024 Bronze Valley Investment Accelerator, Spring 2024 cohort $100,000 SAFE for 5% equity Bronze Valley, administered by gener8tor Independent
By Oct 2024 Total raised, third party estimate $230,000 Not itemized beyond Y Combinator, gener8tor and Bronze Valley Investment Accelerator, gBETA Future of Mobility, TK and Partners, named among “8 more” unnamed investors Independent
Not dated Angel or seed capital referenced by Cocoon Capital’s portfolio page Not disclosed Cocoon Capital lists Adravision on its site; the page does not state a check size or date Independent

What the filings show

No Form D or other Regulation D notice was found for Adravision or for its FDA applicant name, Adra Corporation, in an EDGAR full text search or an EDGAR company search covering Form D filings. That is consistent with a company whose disclosed checks, a Y Combinator seed investment and a Bronze Valley SAFE, are both small enough and structured in ways that do not always require a Form D, and with a company whose home jurisdiction is Singapore, which has no Form D equivalent requirement. It does not confirm that no securities were sold under an exemption that requires no filing, such as Section 4(a)(2).

Reading the numbers

  1. The company’s own number is twice the accelerator’s number.Hamed Fesharaki told TechCrunch in August 2021 that Adravision had raised 250,000 dollars. A registry aggregator (Tracxn) records only a 125,000 dollar Y Combinator seed check dated September 2, 2021. No source reconciles the gap; it may reflect angel money raised alongside the Y Combinator check, or it may reflect rounding or estimation in one of the two figures.
  2. A named, dated, third party check exists for 2024.The Bronze Valley Investment Accelerator, run with gener8tor, put 100,000 dollars into Adravision as one of five companies in its Spring 2024 cohort, structured as a SAFE for 5 percent equity under the program’s stated terms. That figure is corroborated by two independent sources, Bham Now’s cohort announcement and gener8tor’s own program page.
  3. The accelerator came with a relocation.Bronze Valley’s published eligibility rules require portfolio companies to be U.S.-based, founded by U.S. citizens, and to relocate to Birmingham, Alabama or Wilmington, Delaware for the twelve week program. Adravision, a Singapore-founded company, is nonetheless listed by name in the 2024 cohort and by CB Insights and LinkedIn as based in Atlanta, Georgia since around that time, a discrepancy this page cannot resolve from the sources found.
  4. No SEC paper trail exists under either name.Neither “Adravision” nor “Adra Corporation,” the name on the company’s FDA clearance, appears in an EDGAR full text search of Form D or any other filing type. A U.S. capital raise by a foreign-founded startup does not always require SEC disclosure, so the absence is informative but not conclusive.
  5. The filer name and the brand name do not match.The FDA’s public device database lists the applicant behind Adravision Perio as Adra Corporation, based in Atlanta, GA, while the company markets itself and its website as Adravision or Adra. This is common when a brand and its legal entity diverge, but it means a search for “Adravision” alone in a regulatory database would miss the filing.

Commercial signals

Signal Detail Source type
Regulatory FDA 510(k) K232440, cleared Dec 5, 2023, for periodontal bone level measurement only. Public record
Partnership Fluent, a dental analytics and utilization review company backed by The Beekman Group, agreed in October 2024 to build Adravision’s AI into its payer-facing platform. Partner-stated
Accelerators Y Combinator (S21, 2021); gener8tor Bronze Valley Investment Accelerator (Spring 2024); Georgia Tech’s Advanced Technology Development Center; selected as a Venture Atlanta 2026 showcase company. Independent
Pipeline Named a top 10 finalist for CHISEL Healthcare InnoMatch 2026 in Singapore, a program tied to the country’s public healthcare system, pitching Oct 2, 2026. Company-stated
Customers No dental clinic, DSO or insurer has been named publicly as a paying customer as of this research. Not found

What to watch

  • Any SEC filing, or its absence, once or if Adravision raises a priced U.S. round.
  • Named investors beyond Y Combinator and Bronze Valley; CB Insights lists several more without naming all of them.
  • Whether the Singapore entity, ADRA GLOBAL PTE. LTD., or a separate U.S. entity becomes the primary fundraising vehicle going forward.
  • The outcome of the CHISEL Healthcare InnoMatch 2026 pitch and any resulting Singapore public sector work.

The Adravision story on Healthcare DiscoveryHealthcare Discovery

Related companies

  • Onederful: Also in Healthcare IT. A tiny company wired dental software straight into hundreds of insurance carriers, then sold to the clearinghouse Vyne in December 2021
  • Arini: Also in Healthcare IT. A voice AI receptionist built for dental practices and dental service organizations, answering calls and texts and booking appointments directly into a clinic's existing
  • Health Harbor: Also in Healthcare IT. A Y Combinator backed startup whose AI agent calls health insurance companies on behalf of medical clinics, chasing down benefits, prior authorizations and claim status
  • Candid Health: Also in Healthcare IT. Billing software built to get a medical claim right before it ever leaves the clinic, now sold to more than 200 provider organizations

Sources

  1. Public recordFDA 510(k) database entry, K232440, applicant Adra CorporationFDA openFDA · decision Dec 5, 2023
  2. Public recordEDGAR full text and company search for Adravision and Adra Corporation, Form DSEC · searched Sep 2026, no results
  3. IndependentY Combinator-backed Adra wants to turn all dentists into cavity-finding ‘super dentists’TechCrunch, Christine Hall · Aug 23, 2021
  4. IndependentAdra company profile, funding rounds and legal entityTracxn · accessed Sep 2026
  5. IndependentAdravision company profile and funding data, total raised $230KCB Insights · accessed Sep 2026, news dated Oct 17, 2024
  6. Independent5 new startups awarded $500K by Bronze Valley Accelerator, including one from BirminghamBham Now, Nathan Watson · Feb 8, 2024
  7. IndependentBronze Valley Investment Accelerator Powered by gener8tor, program termsgener8tor · accessed Sep 2026
  8. IndependentTop 5 dental startups in Southeast AsiaTech Collective · Apr 10, 2023
  9. CompanyFluent Announces New AI-Powered Oral Health Platform Software through Adravision PartnershipWebWire press release · Oct 17, 2024
  10. CompanyAdravision company profile and founder biosCocoon Capital · Apr 12, 2023
  11. CompanyAdravision company page and recent updates, Venture Atlanta and CHISEL InnoMatch postsLinkedIn · accessed Sep 2026

Compiled from SEC and other public records and published reports as of September 24, 2026. Form D notices report offerings under Regulation D; amounts reflect the filing date. Healthcare Venture Capital Fund holds no position in Adravision. This page is not an offer to sell or a recommendation to buy any security.